President and Fellows of Harvard College;Eisai R&；D Management Co., LTD.
发明人:
Yoshito Kishi,Kazunobu Kira,Ken Ito
申请号：
US16764245
公开号：
US20200325152A1
申请日:
2018.11.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides novel compounds (e.g., compounds of Formulae (I), (II), (III), (IV)) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or pharmaceutically acceptable salts thereof, optionally in a pharmaceutically acceptable carrier, and a medical uses thereof.
